Bard Acquires Neomend Amid Mixed Third Quarter Results
CR Bard Inc. announced the acquisition of private firm NeoMend Inc. Oct. 23 in conjunction with reporting mixed third-quarter results.
This article was originally published in The Gray Sheet
Executive Summary
The deal, which has already closed, will “significantly expand” the business opportunities for Bard’s surgical specialties unit, the firm said.